Pacer Advisors, Inc. Regenxbio Inc. Transaction History

Pacer Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$11.51 - $21.53 $2,854 - $5,339	-248 Reduced 29.7%	587 $6,000
Q1 2024 May 10, 2024	BUY	$12.17 - $24.61 $10,161 - $20,549	835 New	835 $17,000
Q2 2021 Jul 21, 2021	SELL	$32.46 - $40.48 $62,128 - $77,478	-1,914 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$33.61 - $49.95 $6,049 - $8,991	180 Added 10.38%	1,914 $65,000
Q4 2020 Jan 20, 2021	SELL	$26.52 - $49.35 $16,230 - $30,202	-612 Reduced 26.09%	1,734 $79,000
Q3 2020 Oct 19, 2020	BUY	$27.01 - $40.26 $63,365 - $94,449	2,346 New	2,346 $65,000
Q4 2018 Feb 13, 2019	SELL	$39.11 - $75.15 $117,760 - $226,276	-3,011 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $195,715 - $247,353	3,011 New	3,011 $227,000
Q1 2018 May 14, 2018	SELL	$24.05 - $37.5 $10,822 - $16,875	-450 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $11,700 - $15,570	450	450 $15,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $413M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.